Genetic analysis of cell death pathways, drug resistance and oncogenic co-operativity in IL-3 dependent cell lines
Genetic analysis of cell death pathways, drug resistance and oncogenic co-operativity in IL-3 dependent cell lines
批准号:
nhmrc : 384404
负责人:
A/Pr Paul Ekert
金额:
$29.69万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2006
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2006-01-01 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ultimate fate of most of our cells is to die by committing suicide, because they are no longer required, are no longer functioning, or are potentially harmful. This normal physiological process is termed apoptosis . Inappropriate apoptosis can contribute to cell loss following heart attacks, stroke or neurodegenerative diseases, such as Alzheimer s or Parkinson s disease. Conversely, when cell death fails to occur, abnormal cells can accumulate and lead to cancer. In addition, because drugs that are used to treat cancer may exert their effect by inducing apoptosis, a failure of this suicide response may cause resistance to chemotherapy. The genes of the apoptosis pathway function either to promote or inhibit cell death. We have found that some genes in the apoptosis pathway allow apoptosis to proceed rapidly, but do not decide the fate of the cell. Other genes are required for a cell to commit to die. If these genes are mutated then apoptosis does not occur and a functional cell may survive. The distinction between cells that decide fate and those that do not is crucial because it is only the genes that decide cell fate that can act as cancer genes, and are valid targets for therapy. We use a model in which apoptosis is caused by removal of a growth factor, using cell lines derived from mice that lack particular genes in the cell death pathway. These cells proliferate normally in the presence of growth factor, and allow us to determine the role of the genes when growth factor is withdrawn. Because these cells are sensitive to chemotherapeutic drugs, we can also determine the contribution these genes make to cancer drug sensitivity. Using this system, we have discovered that Puma, a gene known to be required for apoptosis in response to radiation, is also a critical activator of apoptosis following growth factor withdrawal. We will determine the manner in which Puma is regulated by growth factors, as well as identify and characterise other key components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target
-
批准号:nhmrc : GNT1103244
-
项目类别:Project Grants
-
资助金额:$60.2万
-
财政年份:2016
-
负责人:A/Pr Paul Ekert
-
依托单位:
Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target
-
批准号:nhmrc : 1103244
-
项目类别:Project Grants
-
资助金额:$41.28万
-
财政年份:2016
-
负责人:A/Pr Paul Ekert
-
依托单位:
Does CD123 provide a biological advantage to leukaemia stem cells?
-
批准号:nhmrc : 1048071
-
项目类别:Project Grants
-
资助金额:$43.18万
-
财政年份:2013
-
负责人:A/Pr Paul Ekert
-
依托单位:
Molecular characterisation of a new survival pathway in haematopoietic cells
-
批准号:nhmrc : 1022916
-
项目类别:Project Grants
-
资助金额:$38.12万
-
财政年份:2012
-
负责人:A/Pr Paul Ekert
-
依托单位:
Identifying the critical components of growth factor-mediated survival pathways
-
批准号:nhmrc : 565212
-
项目类别:NHMRC Project Grants
-
资助金额:$39.3万
-
财政年份:2009
-
负责人:A/Pr Paul Ekert
-
依托单位:
The Role of Hox Genes in Myeloid Cell Development and Myeloid Leukaemia
-
批准号:nhmrc : 546438
-
项目类别:NHMRC Project Grants
-
资助金额:$39.43万
-
财政年份:2009
-
负责人:A/Pr Paul Ekert
-
依托单位:
Aspects of molecular mechanisms of cell death: molecular mechanisms of growth factor withdrawal induced apoptosis and th
-
批准号:nhmrc : 216732
-
项目类别:Career Development Fellowships
-
资助金额:$19.84万
-
财政年份:2002
-
负责人:A/Pr Paul Ekert
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
-
批准号:--
-
项目类别:合作创新研究团队
-
资助金额:--
-
批准年份:2024
-
负责人:姚韬
-
依托单位:
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:USHARANI HAREESH GOVINDARA JAN
-
依托单位:
利用全基因组关联分析和QTL-seq发掘花生白绢病抗性分子标记
-
批准号:31971981
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:晏立英
-
依托单位:
基于SERS纳米标签和光子晶体的单细胞Western Blot定量分析技术研究
-
批准号:31900571
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:刘兵
-
依托单位:
利用多个实验群体解析猪保幼带形成及其自然消褪的遗传机制
-
批准号:31972542
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2019
-
负责人:郭源梅
-
依托单位:
基于Meta-analysis的新疆棉花灌水增产模型研究
-
批准号:41601604
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2016
-
负责人:赵爱琴
-
依托单位:
基于个体分析的投影式非线性非负张量分解在高维非结构化数据模式分析中的研究
-
批准号:61502059
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2015
-
负责人:刘昶
-
依托单位:
多目标诉求下我国交通节能减排市场导向的政策组合选择研究
-
批准号:71473155
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2014
-
负责人:柴建
-
依托单位:
大规模微阵列数据组的meta-analysis方法研究
-
批准号:31100958
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:赵洪雅
-
依托单位:
基于物质流分析的中国石油资源流动过程及碳效应研究
-
批准号:41101116
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:刘晓洁
-
依托单位: